This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2014-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Leuven, BE (2020)
- Tessenderlo, BE (2014 - 2021)
Company Filing History:
Years Active: 2014-2021
Title: Sofie Jeanne Leopoldine Celen: Innovator in Pharmaceutical Sciences
Introduction
Sofie Jeanne Leopoldine Celen is a prominent inventor based in Tessenderlo, Belgium. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for medical imaging and treatment.
Latest Patents
Celen holds three patents, showcasing her innovative work. Her latest patents include "Radiolabelled mGluR2 PET ligands," which relates to selective radiolabelled mGluR2 ligands useful for imaging and quantifying the metabotropic glutamate receptor mGluR2 in tissues using positron-emission tomography (PET). This invention also encompasses compositions and processes for preparing these compounds, as well as their applications in imaging tissues, cells, or mammals. Another notable patent is for "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives," which are inhibitors of phosphodiesterase 2 (PDE2) and phosphodiesterase 10 (PDE10). This invention includes pharmaceutical compositions and methods for treating disorders related to these enzymes, along with radiolabelled compounds for imaging PDE2 in tissues.
Career Highlights
Celen is currently associated with Janssen Pharmaceutica NV, where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the pharmaceutical industry, contributing to innovative solutions for complex medical challenges.
Collaborations
Some of her notable coworkers include José Ignacio Andrés-Gil and Guy Maurits R Bormans. Their collaborative efforts have further enhanced the impact of her inventions in the field.
Conclusion
Sofie Jeanne Leopoldine Celen is a trailblazer in pharmaceutical innovation, with a focus on developing advanced compounds for medical applications. Her contributions are paving the way for future advancements in medical imaging and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile